The device uses external ultrasound pulses to facilitate the passage of residual fragments in a clinical setting.

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

First Patient Enrolled in Trial to Evaluate Safety and Feasibility of Innovative Embolic Agent in Expanded Patient Population Utilizing Middle Meningeal Artery Embolization (MMAe) Arsenal Medical, a ...

Abbott's Freestyle Libre 2 and 3 are the first CGMs to receive FDA clearance for use during imaging tests like X-rays, CT scans, and MRIs.

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

Ovid Therapeutics is pumping the brakes on a planned phase 2 trial for its ROCK2 inhibitor in a type of brain lesion while it ...

Mophie has three new Qi2 charging accessories available as of today from Apple retail stores, including a 3-in-1 Travel ...

With the presidential election season behind us, a major source of uncertainty has been lifted, creating an ideal opportunity for investors to ...

The data thus far suggest fewer repeat interventions with the newly FDA approved resorbable device compared with PTA.

A study noted an average weight loss of 17.6% with Allurion’s device in patients who had no or less than 5% weight loss with ...